These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35769339)

  • 21. COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study.
    Shehab M; Alrashed F; Alfadhli A
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece.
    Galanis P; Vraka I; Katsiroumpa A; Siskou O; Konstantakopoulou O; Katsoulas T; Mariolis-Sapsakos T; Kaitelidou D
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Association between Risk Perception and Hesitancy toward the Booster Dose of COVID-19 Vaccine among People Aged 60 Years and Older in China.
    Qin C; Yan W; Tao L; Liu M; Liu J
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drivers of and Barriers to COVID-19 Vaccine Booster Dose Acceptance in Indonesia.
    Harapan H; Fathima R; Kusuma HI; Anwar S; Nalapraya WY; Wibowo A; Wati KDK; Medina A; Defrita AH; Astri Y; Prasetyowati A; Nurfarahin N; Khusna A; Oktariana S; Anwar S; Yussar MO; Khotimah S; Nainggolan BWM; Badri PRA; Argarini R; Winardi W; Indah R; Sallam M; Rajamoorthy Y; Wagner AL; Mudatsir M
    Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between social media use and hesitancy toward COVID-19 vaccine booster shots in China: A web-based cross-sectional survey.
    Wang R; Qin C; Du M; Liu Q; Tao L; Liu J
    Hum Vaccin Immunother; 2022 Nov; 18(5):2065167. PubMed ID: 35671384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Egyptian hemodialysis patients' willingness to receive the COVID-19 vaccine booster dose: a multicenter survey.
    Abdulaziz HMM; Saleh MA; Elrggal ME; Omar ME; Hawash SA; Attiya AMN; Salem KM; Sabry AA
    J Nephrol; 2023 Jun; 36(5):1329-1340. PubMed ID: 36862285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptance of Annual Booster Doses of COVID-19 Vaccines Among Indian Healthcare Professionals: A Pan-India Cross-Sectional Survey.
    Krishna E; Karthikeyan V; Ahmad S; Ranjan A; Hasan Km A; Pandey S; Kumar P; Singh CM
    Cureus; 2023 Nov; 15(11):e49363. PubMed ID: 38146559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-dimensional potential factors influencing COVID-19 vaccine booster acceptance and hesitancy among university academic community in Bangladesh: A cross-sectional comparative study.
    Roy DN; Azam MS; Islam E
    PLoS One; 2023; 18(4):e0281395. PubMed ID: 37053270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study.
    Dziedzic A; Issa J; Hussain S; Tanasiewicz M; Wojtyczka R; Kubina R; Konwinska MD; Riad A
    Front Public Health; 2022; 10():938067. PubMed ID: 35958845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the Knowledge, Attitudes, and Practices of Indian Medical Students Towards Coronavirus Disease 2019 (COVID-19) After Two Doses of Vaccination and Their Approach Towards the Third (Booster) Dose.
    Banerjee S; Sarvottam K; Gupta AK
    Cureus; 2024 Mar; 16(3):e55588. PubMed ID: 38576675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 Vaccine Booster Hesitancy among the Elderly in Malaysian Residential Care Homes: A Cross-Sectional Study in Klang Valley.
    Lee KW; Yap SF; Ong HT; Liew SL; Oo M; Swe KMM
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uptake of COVID-19 Booster Dose among Saudi Arabian Population.
    Alshahrani NZ; Alsabaani AA; Ridda I; Rashid H; Alzahrani F; Almutairi TH; Alzahrani BAS; Albeshri ASS
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888690
    [No Abstract]   [Full Text] [Related]  

  • 33. Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey.
    Noh Y; Kim JH; Yoon D; Choe YJ; Choe SA; Jung J; Lee SW; Shin JY
    Epidemiol Health; 2022; 44():e2022061. PubMed ID: 35914771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is knowledge about COVID-19 associated with willingness to receive vaccine, vaccine uptake, and vaccine booster uptake in rural Malang, Indonesia?
    Sujarwoto S; Maharani A
    Front Public Health; 2023; 11():1203550. PubMed ID: 37351094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
    AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
    J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.
    Mallory RM; Formica N; Pfeiffer S; Wilkinson B; Marcheschi A; Albert G; McFall H; Robinson M; Plested JS; Zhu M; Cloney-Clark S; Zhou B; Chau G; Robertson A; Maciejewski S; Hammond HL; Baracco L; Logue J; Frieman MB; Smith G; Patel N; Glenn GM;
    Lancet Infect Dis; 2022 Nov; 22(11):1565-1576. PubMed ID: 35963274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial.
    Thakkar A; Pradhan K; Duva B; Carreno JM; Sahu S; Thiruthuvanathan V; Campbell S; Gallego S; Bhagat TD; Rivera J; Choudhary G; Olea R; Sabalza M; Shapiro LC; Lee M; Quinn R; Mantzaris I; Chu E; Will B; Pirofski LA; Krammer F; Verma A; Halmos B
    Elife; 2023 Mar; 12():. PubMed ID: 36975207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey.
    Hong J; Xu XW; Yang J; Zheng J; Dai SM; Zhou J; Zhang QM; Ruan Y; Ling CQ
    J Integr Med; 2022 Jan; 20(1):34-44. PubMed ID: 34774463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid Rollout and Initial Uptake of a Booster COVID-19 Vaccine Among Israel Defense Forces Soldiers.
    Talmy T; Nitzan I
    J Prev (2022); 2023 Feb; 44(1):1-14. PubMed ID: 35972594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China.
    Tung TH; Lin XQ; Chen Y; Zhang MX; Zhu JS
    Expert Rev Vaccines; 2022 Feb; 21(2):261-267. PubMed ID: 34894991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.